Our studies are the first to examine the intersection of p120ctn down-regulation and EGFR overexpression, though we hypothesize that these genetic alterations most likely traverse in many cancer types in addition to ESCC. This evidence concerns the gene CTNND1 and esophageal squamous cell carcinoma.